Insider Trading Summary for Intellia Therapeutics, Inc. (NTLA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Jun-24 5:00 PM View:	17-Jun-24 Sale (Planned) ($37.62K)	Verwiel Frank Director		Intellia Therapeutics, Inc. - NTLA	53% 11.72K to 17.95K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Leonard John M. President and CEO Director		Intellia Therapeutics, Inc. - NTLA	11% 916.28K to 1.02M	0	0	--	--	Show Txns Hide Txns

14-Jun-24 4:20 PM View:	12-Jun-24 Grant 0	Goodman Jesse Director		Intellia Therapeutics, Inc. - NTLA	66% 11.72K to 19.45K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Goddard Glenn EVP, Chief Financial Officer		Intellia Therapeutics, Inc. - NTLA	61% 42.89K to 69.21K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 4:19 PM View:	12-Jun-24 Grant 0	Cohen Fred E Director		Intellia Therapeutics, Inc. - NTLA	19% 41.72K to 49.45K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Sepp-Lorenzino Laura EVP, Chief Scientific Officer		Intellia Therapeutics, Inc. - NTLA	70% 48.23K to 81.89K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Lebwohl David EVP, Chief Medical Officer		Intellia Therapeutics, Inc. - NTLA	63% 57.03K to 93.07K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 4:21 PM View:	12-Jun-24 Grant 0	Keresty Georgia Director		Intellia Therapeutics, Inc. - NTLA	48% 16.15K to 23.88K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	04-Mar-24 Sale ($75.78K)	Basta James EVP, General Counsel		Intellia Therapeutics, Inc. - NTLA	48% 55.28K to 81.57K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Hicks Derek EVP, Chief Business Officer		Intellia Therapeutics, Inc. - NTLA	62% 40.86K to 66.38K	0	0	--	--	Show Txns Hide Txns

03-Jul-24 1:15 PM View:	01-Jul-24 Sale ($9.29K)	Clark Eliana EVP, Chief Technical Officer		Intellia Therapeutics, Inc. - NTLA	57% 45.45K to 71.47K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 4:18 PM View:	12-Jun-24 Grant 0	Bhanji Muna Director		Intellia Therapeutics, Inc. - NTLA	64% 12.0K to 19.73K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 4:16 PM View:	12-Jun-24 Grant 0	Chase William J Director		Intellia Therapeutics, Inc. - NTLA	41% 18.96K to 26.69K	0	0	--	--	Show Txns Hide Txns

17-Jun-24 5:14 PM View:	13-Jun-24 Grant 0	Goff Brian Director		Intellia Therapeutics, Inc. - NTLA	100% 0 to 15.41K	0	0	--	--	Show Txns Hide Txns

24-Jul-24 4:17 PM View:	22-Jul-24 Grant 0	Dulac Edward J III EVP, Chief Financial Officer		Intellia Therapeutics, Inc. - NTLA	100% 0 to 66.32K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 5:29 PM View:	02-Oct-24 Sale ($38.25K)	Dube Michael P VP, Chief Accounting Officer		Intellia Therapeutics, Inc. - NTLA	51% 31.22K to 47.01K	0	0	--	--	Show Txns Hide Txns

Intellia Therapeutics, Inc. (NTLA)

Last Year

24-Nov-23 -- 23-Nov-24

Company Sentiment

Other

Other

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--